Furthermore, tocilizumab, an IL-6 receptor-neutralizing antibody, appears as a putative treatment in some cases of OCD as this molecule was always found effective in some autoimmune disorders where IL-6 is involved [19]. This evidence concerns the gene IL6 and autoimmune disease.